Decitabine Followed by Mitoxantrone Hydrochloride, Etoposide, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes

Clinical trial NCT01729845 · COMPLETED

Trial details

NCT number: NCT01729845
Sponsor: Fred Hutchinson Cancer Center
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Previously Treated Myelodysplastic Syndrome Recurrent Adult Acute Myeloid Leukemia

Start date: 2012-12-20
Primary completion: 2016-08-25
Enrollment: 52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.